Enavate Sciences GP, LLC
NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$279.8M2026 Q3
Positions8
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%
Enavate Sciences GP, LLC reported 8 positions worth $279.8M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: ZBIO (28.1%). Biggest move: new buy BRVE ($74.2M).
8 positions shown
| # | Symbol | Company | Value ↓ | % Port. | Shares | 1Y | YTD | Since reported |
|---|---|---|---|---|---|---|---|---|
| ▸ 1 | ZBIO | $78.7M | 28.14% | 2,919,159 | — | — | — | |
| ▸ 2 | IMNM | $77.7M | 27.79% | 3,613,799 | — | — | -12.7% | |
| ▸ 3 | BRVE | $74.2M | 26.53% | 3,674,656 | — | — | -2.9% | |
| ▸ 4 | SION | $13.0M | 4.66% | 2,478,030 | — | — | -36.7% | |
| ▸ 5 | UPB | $13.0M | 4.63% | 2,459,703 | — | — | -47.2% | |
| ▸ 6 | BBOT | $10.8M | 3.85% | 2,626,946 | — | — | -47.8% | |
| ▸ 7 | CMPX | $8.1M | 2.90% | 7,788,150 | — | — | -25.6% | |
| ▸ 8 | CAMP | $4.2M | 1.50% | 1,041,127 | — | — | -5.9% |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
Frequently Asked Questions
What stocks does Enavate Sciences GP, LLC hold as of Q3 2026?
Enavate Sciences GP, LLC reported 8 positions worth $279.8M in its Q3 2026 13F filing. Largest positions: ZBIO (28.1%), IMNM (27.8%), BRVE (26.5%), SION (4.7%) and UPB (4.6%).
What did Enavate Sciences GP, LLC buy in Q3 2026?
New positions: BRVE.
What did Enavate Sciences GP, LLC sell in Q3 2026?
Reduced: ZBIO and CAMP.
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.